Garg S, Ochetto A, Hu J, Wang J
Viruses. 2025; 17(1).
PMID: 39861834
PMC: 11768703.
DOI: 10.3390/v17010048.
Delghandi S, Raoufinia R, Shahtahmasbi S, Meshkat Z, Gouklani H, Gholoobi A
Heliyon. 2024; 10(17):e37097.
PMID: 39281486
PMC: 11402251.
DOI: 10.1016/j.heliyon.2024.e37097.
Mironova M, Ghany M
Vaccines (Basel). 2024; 12(4).
PMID: 38675820
PMC: 11053833.
DOI: 10.3390/vaccines12040439.
Kramvis A, Mammas I, Spandidos D
Biomed Rep. 2023; 19(1):48.
PMID: 37383679
PMC: 10293880.
DOI: 10.3892/br.2023.1631.
Gerlich W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022; 65(2):170-182.
PMID: 35015108
PMC: 8751463.
DOI: 10.1007/s00103-021-03484-w.
Finding the key to solving problems in the hepatitis kingdom: A Study on the Development of Hepatitis B Vaccine by Kim Chung Young in the 1960-70s.
Shin M
Uisahak. 2020; 29(2):537-567.
PMID: 32937642
PMC: 10565053.
DOI: 10.13081/kjmh.2020.29.537.
Hepatitis B vaccine development and implementation.
Zhao H, Zhou X, Zhou Y
Hum Vaccin Immunother. 2020; 16(7):1533-1544.
PMID: 32186974
PMC: 7482909.
DOI: 10.1080/21645515.2020.1732166.
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.
Ho J, Jeevan-Raj B, Netter H
Viruses. 2020; 12(2).
PMID: 31973017
PMC: 7077199.
DOI: 10.3390/v12020126.
Vaccine technologies: From whole organisms to rationally designed protein assemblies.
Karch C, Burkhard P
Biochem Pharmacol. 2016; 120:1-14.
PMID: 27157411
PMC: 5079805.
DOI: 10.1016/j.bcp.2016.05.001.
Hepatitis Vaccines.
Ogholikhan S, Schwarz K
Vaccines (Basel). 2016; 4(1).
PMID: 26978406
PMC: 4810058.
DOI: 10.3390/vaccines4010006.
Hepatitis B Vaccination in Pregnancy in the United States.
Stewart R, Sheffield J
Vaccines (Basel). 2015; 1(2):167-73.
PMID: 26343965
PMC: 4515586.
DOI: 10.3390/vaccines1020167.
Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.
Gerlich W
Med Microbiol Immunol. 2014; 204(1):39-55.
PMID: 25523195
DOI: 10.1007/s00430-014-0373-y.
Medical virology of hepatitis B: how it began and where we are now.
Gerlich W
Virol J. 2013; 10:239.
PMID: 23870415
PMC: 3729363.
DOI: 10.1186/1743-422X-10-239.
Bioterrorism, embryonic stem cells, and Frankenstein.
Guinan P
J Relig Health. 2003; 41(2):305-9.
PMID: 12728944
DOI: 10.1023/a:1021118308862.
Update on diagnosis, management, and prevention of hepatitis B virus infection.
Mahoney F
Clin Microbiol Rev. 1999; 12(2):351-66.
PMID: 10194463
PMC: 88921.
DOI: 10.1128/CMR.12.2.351.
Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.
Ogata N, Ostberg L, Ehrlich P, Wong D, Miller R, Purcell R
Proc Natl Acad Sci U S A. 1993; 90(7):3014-8.
PMID: 8464917
PMC: 46227.
DOI: 10.1073/pnas.90.7.3014.
Immunisation against hepatitis B.
Br Med J. 1980; 281(6255):1585-6.
PMID: 7448523
PMC: 1715065.
Hepatitis virus vaccines: present status.
Krugman S
Yale J Biol Med. 1982; 55(3-4):375-81.
PMID: 6295013
PMC: 2596435.
Hepatocellular carcinoma- etiologic considerations: a review of the literature.
Worrell R, Moazami M, Worrell L
J Natl Med Assoc. 1981; 73(7):601-7.
PMID: 6267318
PMC: 2553017.
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.
Prince A, Ikram H, Hopp T
Proc Natl Acad Sci U S A. 1982; 79(2):579-82.
PMID: 6176997
PMC: 345788.
DOI: 10.1073/pnas.79.2.579.
